Flexion Therapeutics EPS in-line, misses on revenue

May 08, 2019 4:14 PM ETPacira BioSciences, Inc. (PCRX)By: Mohit Manghnani, SA News Editor6 Comments
  • Flexion Therapeutics (FLXN): Q1 GAAP EPS of -$1.09 in-line.
  • Revenue of $10.6M (+384.0% Y/Y) misses by $0.39M.
  • Shares +2.9%.
  • Press Release

Recommended For You

Comments (6)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.